GlaxoSmithKline PLC — Director's Dealing 2016

Mar 22, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9399S

GlaxoSmithKline PLC

22 March 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R (1) (a) I give details of changes in the interests of Roger Connor, a Person Discharging Managerial Responsibility, in the Ordinary Shares of GlaxoSmithKline plc (the "Company") following:

1.   the exercise of a nil cost option over 3,680 Ordinary Shares on 22 March 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan;

2.   the sale of 3,680 Ordinary shares on 22 March 2016 at a price of £13.78 per share; and

3.   the sale of 19,320 Ordinary Shares on 22 March 2016 at a price of £13.76 per share.

The Company and Mr Connor were advised of these transactions on 22 March 2016.

V A Whyte

Company Secretary

22 March 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSELLFLQXFFBBX